ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
Dow Jones
44.296,51
0,97%
Euro vs US Dollar
1,0418
0,00%
Bitcoin
97.923,94
-1,12%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Conduit Pharmaceuticals Inc (CDTTW)

  7. Conduit Pharmaceuticals Inc (CDTTW) News

CDTTW

Conduit Pharmaceuticals (CDTTW)

Conduit Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CDTTW
DatumZeitQuelleÜberschriftSymbolFirma
20/11/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
20/11/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
20/11/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
19/11/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTTWConduit Pharmaceuticals Inc
14/11/202423h27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDTTWConduit Pharmaceuticals Inc
14/11/202423h24Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
14/11/202423h22Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
14/11/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTTWConduit Pharmaceuticals Inc
06/11/202412h01Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
04/11/202423h21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CDTTWConduit Pharmaceuticals Inc
04/11/202423h20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CDTTWConduit Pharmaceuticals Inc
04/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CDTTWConduit Pharmaceuticals Inc
01/11/202422h10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CDTTWConduit Pharmaceuticals Inc
01/11/202421h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTTWConduit Pharmaceuticals Inc
28/10/202422h17Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CDTTWConduit Pharmaceuticals Inc
28/10/202422h16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CDTTWConduit Pharmaceuticals Inc
28/10/202422h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CDTTWConduit Pharmaceuticals Inc
24/10/202412h12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CDTTWConduit Pharmaceuticals Inc
18/10/202422h15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
16/10/202423h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CDTTWConduit Pharmaceuticals Inc
15/10/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDTTWConduit Pharmaceuticals Inc
08/10/202401h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
08/10/202401h36Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDTTWConduit Pharmaceuticals Inc
02/10/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDTTWConduit Pharmaceuticals Inc
29/05/202422h21GlobeNewswire Inc.A Presidio Property Trust Major Investment To Be Part of Russell 2000®NASDAQ:CDTTWConduit Pharmaceuticals Inc
06/10/202314h30GlobeNewswire Inc.Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)NASDAQ:CDTTWConduit Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CDTTW

Kürzlich von Ihnen besucht

BIT
F29238
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten